China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) issued its earnings results on Wednesday. The company reported ($0.05) EPS for the quarter, RTT News reports. China Pharma Holdings had a negative return on equity of 15.88% and a negative net margin of 78.43%. During the same period last year, the company posted ($0.04) EPS.
China Pharma Holdings (NYSEAMERICAN:CPHI) opened at $0.18 on Thursday. China Pharma Holdings has a 52 week low of $0.15 and a 52 week high of $0.35.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.themarketsdaily.com/2017/11/16/china-pharma-holdings-inc-cphi-announces-quarterly-earnings-results.html.
China Pharma Holdings Company Profile
China Pharma Holdings, Inc is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co, Ltd. (Helpson) in the People’s Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC.
Receive News & Ratings for China Pharma Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.